Amgen is integrating artificial intelligence into its clinical development processes to accelerate drug discovery and improve trial efficiency. The company is exploring AI for tasks such as identifying patient cohorts, optimizing trial design, and analyzing complex biological data. This strategic adoption aims to bring new therapies to patients faster and more effectively. AI
影响 Accelerates drug discovery timelines and enhances clinical trial efficiency through AI integration.
排序理由 The cluster discusses the application of AI within a company's existing processes, not a new AI product or core AI research.
在 Mastodon — sigmoid.social 阅读 →
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
